These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 8492226

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pituitary pathology in Cushing's disease.
    Saeger W, Geisler F, Lüdecke DK.
    Pathol Res Pract; 1988 Sep; 183(5):592-5. PubMed ID: 3237549
    [Abstract] [Full Text] [Related]

  • 4. A study of intermediate lobe differentiation in the human pituitary gland.
    McNicol AM.
    J Pathol; 1986 Nov; 150(3):169-73. PubMed ID: 3543273
    [Abstract] [Full Text] [Related]

  • 5. Electron microscopical morphometry of well-differentiated and undifferentiated ACTH secreting adenomas in Cushing's disease and Nelson's syndrome.
    Reuss WA, Saeger W, Lüdecke DK.
    Virchows Arch A Pathol Anat Histopathol; 1991 Nov; 419(5):395-401. PubMed ID: 1661044
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Trilostane-induced inhibition of cortisol secretion results in reduced negative feedback at the hypothalamic-pituitary axis.
    Teshima T, Hara Y, Takekoshi S, Nezu Y, Harada Y, Yogo T, Teramoto A, Osamura RY, Tagawa M.
    Domest Anim Endocrinol; 2009 Jan; 36(1):32-44. PubMed ID: 19041802
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pituitary corticotroph hyperplasia preceding adenoma in a patient with Nelson's syndrome.
    Kovacs K, Horvath E, Coire C, Cusimano M, Smyth H, Scheithauer BW, Lloyd RV.
    Clin Neuropathol; 2006 Jan; 25(2):74-80. PubMed ID: 16550740
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Studies of the basal secretion and the response to TRH (thyrotropin-relapsing factor) of TSH (thyrotropin) and prolactin in Cushing's syndrome and Nelson's syndrome (author's transl)].
    Luton JP, Molinie P, Strauch G, Guilhaume B, Bricaire H.
    Sem Hop; 2006 Jan; 57(17-18):841-9. PubMed ID: 6262921
    [Abstract] [Full Text] [Related]

  • 12. Hyperprolactinemia in Cushing's disease and Nelson's syndrome.
    Yamaji T, Ishibashi M, Teramoto A, Fukushima T.
    J Clin Endocrinol Metab; 1984 May; 58(5):790-5. PubMed ID: 6323516
    [Abstract] [Full Text] [Related]

  • 13. Histopathology of the pituitary.
    Doniach I.
    Clin Endocrinol Metab; 1985 Nov; 14(4):765-89. PubMed ID: 3002676
    [Abstract] [Full Text] [Related]

  • 14. Low level of glucocorticoid receptor messenger ribonucleic acid in pituitary adenomas manifesting Cushing's disease with resistance to a high dose-dexamethasone suppression test.
    Mu YM, Takayanagi R, Imasaki K, Ohe K, Ikuyama S, Yanase T, Nawata H.
    Clin Endocrinol (Oxf); 1998 Sep; 49(3):301-6. PubMed ID: 9861319
    [Abstract] [Full Text] [Related]

  • 15. Human corticotroph cell adenomas.
    Robert F, Hardy J.
    Semin Diagn Pathol; 1986 Feb; 3(1):34-41. PubMed ID: 3039631
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Nelson's syndrome and spontaneous pituitary tumor infarction.
    Jordan RM, Cook DM, Kendall JW, Kerber CW.
    Arch Intern Med; 1979 Mar; 139(3):340-2. PubMed ID: 426579
    [Abstract] [Full Text] [Related]

  • 20. Pro-opiomelanocortin gene expression in silent corticotroph-cell adenoma and Cushing's disease.
    Nagaya T, Seo H, Kuwayama A, Sakurai T, Tsukamoto N, Nakane T, Sugita K, Matsui N.
    J Neurosurg; 1990 Feb; 72(2):262-7. PubMed ID: 2153197
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.